Intensive care medicine, 2020-04, Vol.46 (4), p.586-590
2020
Details
- Autor(en) / Beteiligte
- Titel
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- Ist Teil von
- Intensive care medicine, 2020-04, Vol.46 (4), p.586-590
- Ort / Verlag
- Berlin/Heidelberg: Springer Berlin Heidelberg
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- SpringerLink (Online service)
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0342-4642eISSN: 1432-1238DOI: 10.1007/s00134-020-05985-9Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7079879
- Format
- –
- Schlagworte
- ACE inhibitors, ACE2, Alveolar Epithelial Cells - metabolism, Anesthesiology, Angiotensin, Angiotensin-Converting Enzyme 2, Betacoronavirus, Coronavirus, Coronaviruses, COVID-19 vaccines, Critical care, Critical Care Medicine, Disease transmission, Emergency Medicine, Enzymes, Epidemics, Hospitals, Humans, Intensive, Lung diseases, Medical colleges, Medicine, Medicine & Public Health, Molecular modelling, Pain Medicine, Pediatrics, Penninger, Josef, Peptidyl-Dipeptidase A, Pneumology/Respiratory System, Proteins, Receptors, Virus - metabolism, Respiratory Distress Syndrome - drug therapy, RNA, Viral, SARS-CoV-2, Severe Acute Respiratory Syndrome - complications, Severe Acute Respiratory Syndrome - enzymology, Severe Acute Respiratory Syndrome - virology, Severe acute respiratory syndrome coronavirus 2, Spike Glycoprotein, Coronavirus, Therapeutic applications, Understanding the Disease, Viral Envelope Proteins - metabolism, Viruses